CN Patent

CN105745206B — 用于治疗疾病的葡萄糖神经酰胺合成酶抑制剂

Assigned to Biomarin Pharmaceutical Inc · Expires 2019-08-13 · 7y expired

What this patent protects

本文描述了式I的化合物、制备这类化合物的方法、含有这类化合物的药物组合物和药物，以及使用这类化合物治疗或预防与葡萄糖神经酰胺合成酶(GCS)这种酶有关的疾病或病症的方法。

USPTO Abstract

本文描述了式I的化合物、制备这类化合物的方法、含有这类化合物的药物组合物和药物，以及使用这类化合物治疗或预防与葡萄糖神经酰胺合成酶(GCS)这种酶有关的疾病或病症的方法。

Drugs covered by this patent

eliglustat-tartrate (ELIGLUSTAT TARTRATE)

Patent Metadata

Patent number: CN105745206B
Jurisdiction: CN
Classification: —
Expires: 2019-08-13
Drug substance claim: No
Drug product claim: No
Assignee: Biomarin Pharmaceutical Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.